References
-
Anrather, J., G. Racchumi, and C. Iadecola. 2005. Cis-acting element-specific transcriptional activity of differentially phosphorylated NF-
${\kappa}B$ . J. Biol. Chem. 280: 244-252 https://doi.org/10.1074/jbc.M409344200 -
Arlt, A., J. Vorndamm, M. Breitenroich, U. R. Folsh, H. Kalthoff, W. E. Schmidt, and H. Schafer. 2001. Inhibition of NF-
${\kappa}B$ sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20: 859-868 https://doi.org/10.1038/sj.onc.1204168 -
Arlt, A., A. Gehrz, S. Muerkoster, J. Vorndamm, M. L. Kruse, U. Folsch, and H. Schafer. 2003. Role of NF-
${\kappa}B$ and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22: 3243-3251 https://doi.org/10.1038/sj.onc.1206390 -
Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Constitutive NF
${\kappa}B$ activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alphadeficient mice. Genes Dev. 9: 2736-2746 https://doi.org/10.1101/gad.9.22.2736 -
Bottero, V., V. Busuttil, A. Loubat, N. Magne, J. L. Fischel, G. Milano, and J. F. Peyron. 2001. Activation of NF-
${\kappa}B$ through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: A brake to apoptosis in HeLa human carcinoma cells. Cancer Res. 61: 7785-7791 -
Choi, Y. S. and S. Jeong. 2004. New paradigm for the NF-
${\kappa}B$ transcriptional regulation. J. Nano. BioTech. 1: 21- 27 - Ghosh, S., M. J. May, and E. B. Kopp. 1998. Annu. Rev. Immunol. 16: 225-260 https://doi.org/10.1146/annurev.immunol.16.1.225
-
Ghosh, S. 1999. Regulation of inducible gene expression by the transcription factor NF
${\kappa}B$ . Immunol. Res. 19: 183- 189 https://doi.org/10.1007/BF02786486 - Ghosh, S. and M. Karin. 2002. Missing pieces in the NF-Immunol. Res. puzzle. Cell 109: S81-S96 https://doi.org/10.1016/S0092-8674(02)00703-1
-
Hou, S., H. Guan, and R. P. Ricciardi. 2003. Phosphorylation of Serine 337 of NF-
${\kappa}B$ p50 is critical for DNA binding. J. Biol. Chem. 278: 45994-45998 https://doi.org/10.1074/jbc.M307971200 - Ibuki, Y. and R. Goto. 2000. Suppression of apoptosis by UVB irradiation: Survival signaling via PI3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 279: 872-878 https://doi.org/10.1006/bbrc.2000.4018
- Jeong, Y. W., K. S. Kim, J. Y. Oh, J. C. Park, J. H. Bang, S. W. Choi, and J. C. Lee. 2003. Growth inhibition and apoptosis induction of gastric cancer cells by copper (II) glycinate complex. J. Microbiol. Biotechnol. 13: 394-399
- Karpinich, N. O., M. Tafani, R. J. Rothman, M. A. Russo, and J. L. Farber. 2002. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J. Biol. Chem. 277: 16547-16552 https://doi.org/10.1074/jbc.M110629200
- Kim, M. K., Y. H. Cho, J. M. Kim, M. W. Chun, S. K. Lee, Y. H. Lim, and C. H. Lee. 2003. Inhibition of cell-cycle progression in human promyelocytic leukemia HL-60 cells by MCS-C2, novel cyclin-dependent kinase inhibitor. J. Microbiol. Biotechnol. 13: 607-612
- Kim, N. S., K. H. Chang, B. S. Chung, S. H. Kim, J. H. Kim, and G. M. Lee. 2003. Characterization of humanized antibody produced by apoptosis-resistant CHO cells under sodium butyrate-induced condition. J. Microbiol. Biotechnol. 13: 926-936
-
Koul, D., Y. Yao, J. L. Abbruzzese, W. K. A. Yung, and S. A. G. Reddy. 2001. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NF-
$\kappa$ B activation without interfering with the I${\kappa}B$ degradation pathway. J. Biol. Chem. 276: 11402- 11408 https://doi.org/10.1074/jbc.M007806200 - Lee, H. S., M. Y. Jang, J. H. Choi, Y. Y. Lee, H. B. Park, Y. S. Lee, S. W. Kim, and M. J. Ahn. 2003. Proliferation, apoptosis, and telomerase activity in human cord blood CD34+ cells cultured with combinations of various cytokines. J. Microbiol. Biotechnol. 13: 422-428
-
Mitchell, T. and B. Sugden. 1995. Stimulation of NF-
${\kappa}B$ mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69: 2968- 2976 -
Nakano, H., M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, H. Yagita, and K. Okumura. 1998. Differential regulation of I
${\kappa}B$ kinase$\alpha$ and$\beta$ by two upstream kinases, NF${\kappa}B$ inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95: 3537-3542 -
Okazaki, T., S. Sakon, T. Sasazuki, H. Sakurai, T. Doi, H. Yagita, K. Okumura, and H. Nakano. 2003. Phosphorylation of serine 276 is essential for p65 NF-
${\kappa}B$ subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300: 807-812 https://doi.org/10.1016/S0006-291X(02)02932-7 - Osaki, M., M. Oshimura, and H. Ito. 2004. PI3K-Akt pathway: Its function and alterations in human cancer. Apoptosis 9: 667-676 https://doi.org/10.1023/B:APPT.0000045801.15585.dd
-
Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF
${\kappa}B$ activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85 https://doi.org/10.1038/43466 - Rodriguez-Lopez, A. M., D. Xenaki, T. O. B. Eden, J. A. Hickman, and C. M. Chresta. 2000. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. Mol. Pharmacol. 59: 135-143
-
Romashkova, J. and S. S. Makarov. 1999. NF-
${\kappa}B$ is a target of AKT in anti-apoptotic PDGF signaling. Nature 401: 86-89 https://doi.org/10.1038/43474 -
Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. I
${\kappa}B$ kinases phosphorylate NF-${\kappa}B$ p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274: 30353-30356 https://doi.org/10.1074/jbc.274.43.30353 -
Schmitz, M., I. Mattioli, H. Buss, and M. Kracht. 2004. NF-
${\kappa}B$ : A multifaceted transcription factor regulated at several levels. Chembiochem. 5: 1348-1358 https://doi.org/10.1002/cbic.200400144 -
Shishodia, S. and B. B. Aggarwal. 2004. NF-
${\kappa}B$ : A friend or a foe in cancer? Biochem. Pharmacol. 68: 1071-1080 https://doi.org/10.1016/j.bcp.2004.04.026 - Shrikanth, A. G., S. A. G. Reddy, J. H. Huang, and W. S. L. Liao. 2000. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-Biochem. Pharmacol. activation. J. Immunol. 164: 1355- 1363 https://doi.org/10.4049/jimmunol.164.3.1355
-
Sizemore, N., S. Leung, and G. R. Stark. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-
${\kappa}B$ p65/ RelA subunit. Mol. Cell Biol. 19: 4798-4805 -
Tabata, M., R. Tabata, D. R. Grabowski, R. M. Bukowski, M. K. Ganapathi, and R. Ganathi. 2001. Roles of NF-
${\kappa}B$ and 26S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J. Biol. Chem. 276: 8029-8036 https://doi.org/10.1074/jbc.M009831200 -
Wang, C. Y., J. C. Cusack, R. Liu, and A. S. Baldwin. 1999. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-
${\kappa}B$ . Nature Med. 5: 412-417 https://doi.org/10.1038/7410 -
Wang, D., S. D. Westerheide, J. L. Hanson, and A. S. Baldwin. 2000. Tumor necrosis factor
$\alpha$ -induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275: 32592-32597 https://doi.org/10.1074/jbc.M001358200 -
Watanabe, K., M. Kubota, K. Hamahata, Y. W. Lin, and I. Usami. 2002. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-
${\kappa}B$ activation. Biochem. Pharmacol. 60: 823-830 -
Yeh, P. Y., S. E. Chuang, K. H. Yeh, Y. C. Song, and A. L. Cheng. 2002. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF-
${\kappa}B$ activation. Biochem. Pharmacol. 63: 1423-1430 https://doi.org/10.1016/S0006-2952(02)00908-5 -
Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF
${\kappa}B$ determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625- 636 https://doi.org/10.1016/S1097-2765(02)00477-X